drugset / Trial / NCT00407446
PDE5-Inhibition With Sildenafil in Chronic Heart Failure
RandomizedParallel-groupDouble-blindTreatment
Summary
To test the hypothesis that long-term PDE5-inhibition by overexpressing the nitric oxide pathway is beneficial in chronic heart failure patients. Double-blind and placebo-controlled trial. Primary end-points: quality of life and exercise performance
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | — | — |